SCHEMBL7361186

SCHEMBL7361186

CC(C)CC(NC(=O)[C@H](O)[C@H](N)CC1CCCCC1)C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
METAP2 P50579 8/20 0.51
METAP1 P53582 5/20 0.51
REN P00797 2/20 0.46
CPB2 Q96IY4 4/20 0.44
ALDH1A1 P00352 2/20 0.43
MEN1 O00255 1/20 0.43
LMNA P02545 1/20 0.43
KMT2A Q03164 1/20 0.43
PSEN1 P49768 2/20 0.42
PSEN2 P49810 2/20 0.42
APH1B Q8WW43 2/20 0.42
NCSTN Q92542 2/20 0.42
APH1A Q96BI3 2/20 0.42
PSENEN Q9NZ42 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11407267 1.00 METAP2 (0.51) METAP2METAP1RENCPB2ALDH1A1
SCHEMBL11407261 1.00 METAP2 (0.51) METAP2METAP1RENCPB2ALDH1A1
Hydrochloric Acid SCHEMBL7508388 0.99 METAP2 (0.50) METAP2METAP1RENCPB2ALDH1A1
SCHEMBL7351732 0.88 METAP2 (0.49) METAP2METAP1RENPSEN1PSEN2
SCHEMBL7357202 0.85 METAP2 (0.54) METAP2METAP1RENCPB2
SCHEMBL7353581 0.85 METAP2 (0.54) METAP2METAP1RENCPB2
SCHEMBL7353623 0.85 METAP2 (0.54) METAP2METAP1REN
SCHEMBL7357763 0.84 METAP2 (0.53) METAP2METAP1RENCPB2
Hydrochloric Acid SCHEMBL7362265 0.84 METAP2 (0.53) METAP2METAP1REN
SCHEMBL7355867 0.82 METAP2 (0.61) METAP2METAP1RENCPB2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6242494-B1 ANGIOGENESIS INHIBITORS, ANTITUMOR AGENTS, DIABETIC RETINOPATHY, AND ANTIINFLAMMATORY AGENTS ABBOTT LABORATORIES 2001-06-05 US claimed
US-6242494-B1 ANGIOGENESIS INHIBITORS, ANTITUMOR AGENTS, DIABETIC RETINOPATHY, AND ANTIINFLAMMATORY AGENTS ABBOTT LABORATORIES 2001-06-05 US disclosed
EP-1073633-A2 SUBSTITUTED BETA-AMINO ACID INHIBITORS OF METHIONINE AMINOPEPTIDASE-2 ABBOTT LABORATORIES (US) 2001-02-07 EP disclosed
WO-1999057098-A2 SUBSTITUTED BETA-AMINO ACID INHIBITORS OF METHIONINE AMINOPEPTIDASE-2 ABBOTT LABORATORIES (US) 1999-11-11 WO disclosed